Harbin Dandelion Pharmaceutical

Harbin Dandelion Pharmaceutical is a Chinese pharmaceutical manufacturer specializing in Traditional Chinese Medicine (TCM) and chemical drug formulations. Based in Harbin and operating as a subsidiary of Harbin Gloria Pharmaceuticals (Yuheng Pharmaceutical), the company focuses on treatments for cerebrovascular and cardiovascular conditions. Its flagship products include the proprietary TCM formulations Annao Pills and Annao Tablets, which are widely utilized in China for the management of hypertension, headaches, and stroke symptoms. The company maintains GMP-certified facilities for the production of pills, tablets, capsules, and granules, and it is recognized as a high-tech enterprise for its efforts in modernizing traditional herbal remedies into standardized pharmaceutical formats.